כל המחקרים
גיוסתצפיתי

A Study of Bleeding and Treatment in Participants With Von Willebrand Disease

This UK study is collecting important information about Von Willebrand Disease (VWD), a condition where blood doesn't clot properly. Researchers want to understand how different types of VWD (especially Type 1, and potentially Type 2 and 3) impact people's lives, including their bleeding episodes, the treatments they use, and their overall quality of life. The aim is to create a baseline understanding of VWD in the UK. This information will be vital for comparing results from future studies and ultimately helping to develop better treatments and support for those living with VWD. Taking part involves tracking your bleeding and treatments over several months.

במבט חטוף

על מה המחקר הזה?

This study is looking into Von Willebrand Disease (VWD), which is a common inherited bleeding disorder. People with VWD have a problem with a protein in their blood called von Willebrand factor, which helps blood to clot. This can lead to heavy bleeding that lasts longer than usual, for example, from cuts, nosebleeds, heavy periods, or after surgery.

The main goal of this study is to gather a comprehensive picture of what it's like to live with VWD in the UK. Researchers want to collect information on how often people experience bleeding episodes, what treatments they use to manage their bleeding, and how these experiences affect their daily lives and overall well-being. By understanding these factors, the study aims to create a clear snapshot of the current situation for people with VWD.

The information collected will be incredibly valuable. It will help doctors and researchers understand the typical experiences of VWD patients, serving as a benchmark for future research. This means that when new treatments or ways of managing VWD are developed, this study's findings can be used to see if they are making a real difference to people's lives.

נקודות עיקריות

  • It's about understanding real-life experiences with VWD in the UK.
  • No new medicines are given; it's an observational study.
  • Participation involves tracking bleeding and treatments over several months.
  • Your insights will help improve future VWD care.
  • אתה יכול להפסיק להשתתף בכל עת.

מי עשוי להיות זכאי?

To join this study, you need to be between 16 and 69 years old and have been diagnosed with Type 1 or Type 2A Von Willebrand Disease. Your diagnosis must be confirmed by specific blood test results, showing low levels of the von Willebrand factor and another clotting factor called FVIII.

It's important that you experience some bleeding symptoms related to your VWD. This could mean you've had bruising or bleeding that needed treatment at least three times a year, or you regularly experience heavy menstrual bleeding.

There are also some reasons why you might not be able to join. For example, if you have a history of serious allergic reactions to certain medications, a personal history of blood clots (unless it was a mild, catheter-related clot), or if you have other serious bleeding disorders or conditions that significantly increase your risk of blood clots. If you're planning major surgery during the study period or are already on continuous medication to prevent bleeding, you also wouldn't be able to participate.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. Are you between 16 and 69 years old?
  2. Do you have a confirmed diagnosis of Type 1 or Type 2A VWD?
  3. Do you experience bleeding symptoms from your VWD (e.g., at least 3 bleeding episodes per year or regular heavy periods)?
  4. Do you have a Body Mass Index (BMI) below 38.5?
  5. Do you NOT have a history of blood clots or other serious bleeding disorders?
  6. Are you NOT planning major surgery during the next year?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

If you decide to take part, you'll first have a screening visit to check if you're suitable for the study. Then, there will be a baseline evaluation where more information about your VWD will be collected. You'll then enter an observation period lasting about 4 months.

During this 4-month period, you'll have check-ins every two weeks, likely done remotely (like a phone or video call). In these check-ins, you'll discuss entries you've made in a bleed diary, where you'll record any bleeding episodes and what treatments you used. After the initial 4 months, you'll have the option to continue in the study for a longer observation period, up to a total of 12 months.

סיכונים ותועלות פוטנציאליים

Taking part in this study may not directly benefit you, as it's primarily for gathering information. However, your contribution will help healthcare professionals and researchers better understand VWD and could lead to improved treatments and care for others in the future. The risks of this study are generally low, as it mainly involves providing information about your condition and treatments; there are no new medications being tested. You will have regular contact with the study team, which could be reassuring. Remember, your participation is voluntary, and you are free to withdraw from the study at any time without affecting your medical care.

מיקומים (17)

  • בית החולים לילדים פיניקס
    מיקוד מאומת
    פניקס, ארצות הברית· גיוס
  • בית החולים לילדים של ארקנסו
    מיקוד מאומת
    ליטל רוק, ארצות הברית· גיוס
  • Children's Hospital of Los Angeles
    מיקוד מאומת
    לוס אנג'לס, ארצות הברית· גיוס
  • University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center
    מיקוד מאומת
    מיאמי, ארצות הברית· גיוס
  • Emory Children's Center
    מיקוד מאומת
    אטלנטה, ארצות הברית· גיוס
  • Innovative Hematology, Inc./Indiana Hemophilia and Thrombosis Center
    מיקוד מאומת
    אינדיאנפוליס, ארצות הברית· גיוס
  • Tulane University School of Medicine
    מיקוד מאומת
    ניו אורלינס, ארצות הברית· גיוס
  • University of Michigan Hospitals, Department of Hemophilia and Coagulation Disorders
    מיקוד מאומת
    אן ארבור, ארצות הברית· גיוס
  • Mayo Clinic - Rochester
    מיקוד מאומת
    רוצ'סטר, ארצות הברית· גיוס
  • Oregon Health & Science University
    מיקוד מאומת
    פורטלנד, ארצות הברית· גיוס
  • Hemophilia Center of Western Pennsylvania
    מיקוד מאומת
    פיטסבורג, ארצות הברית· גיוס
  • The University of Texas Southwestern Medical Center
    מיקוד מאומת
    דאלאס, ארצות הברית· גיוס

שאלות נפוצות

What is Von Willebrand Disease (VWD)?

VWD is a common inherited bleeding disorder where your blood doesn't clot as it should, leading to longer or heavier bleeding.

מה המחקר מנסה לגלות?

The study wants to understand people's real-life experiences with VWD, including bleeding episodes, treatments, and how it affects their daily lives.

Do I have to take new medicine in this study?

No, this study is about observing your current bleeding and treatment experiences; you will not be given new medicines to test.

כמה זמן אהיה במחקר?

The main part of the study is about 4 months, with an option to continue for up to a total of 12 months.

האם אני יכול לעזוב את המחקר בכל עת?

Yes, you are free to withdraw from the study at any point, and it won't affect your medical care.

כיצד לגלות עוד

Clinical Trials (USA; UK)

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "A Study of Bleeding and Treatment in Participants With Von W…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.